PSUSA/00010767/202310 - periodic safety update report single assessment

levofloxacin (intravenous and oral use)

About

Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.

Key facts

• Active substance(s) in scope of the PSUSA procedure:
  levofloxacin (intravenous and oral use)
• Procedure number:
  PSUSA/00010767/202310
• Regulatory outcome:
  Variation

Documents

Levofloxacin (intravenous and oral use) : List of nationally authorised medicinal products - PSUSA/00010767/202310

Reference Number: EMA/320231/2024

Levofloxacin (intravenous and oral use) : CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00010767/202310